Sharp Therapeutics Corp. (TSXV:SHRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.5000
-0.9500 (-65.52%)
At close: Jun 25, 2025
Market Cap14.99M
Revenue (ttm)n/a
Net Income (ttm)-7.60M
Shares Out29.97M
EPS (ttm)-0.47
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume100
Average Volume2,912
Open0.5000
Previous Close1.4500
Day's Range0.5000 - 0.5000
52-Week Range0.5000 - 2.2800
Betan/a
RSI28.82
Earnings DateAug 21, 2025

About Sharp Therapeutics

Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies, enables discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically; and Mine, a proprietary IP-protected analytics platform that captures all data for all AlloChem compounds in all CoreX assays. Sharp Therapeutics Corp. is headquartered in Pittsburgh, Pennsylvania. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Scott Sneddon
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol SHRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.